Last updated: May 1, 2026, 5:07 am
PSWE-06 - 113 - One Health in action: Global strategies for specialty pharmacy programmes
Tracks
Track 1
| Wednesday, September 2, 2026 |
| 2:15 PM - 3:45 PM |
Details
Organised by the FIP Community Pharmacy Section
Chair(s)
Ms Rafa Al Khalifa, FIP Early Career Pharmacist Group, UAE, and Ms Lynnae Mahaney, Swenson Pharmacy Advisors (SPA), USA
Introduction:
Specialty medications — used to treat complex conditions such as cancer, autoimmune diseases, multiple sclerosis, hepatitis, and HIV—require dedicated clinical expertise and specialised pharmacy models. These therapies are high-cost, involve intensive monitoring, and demand operational systems that often vary significantly by region.
This panel will feature specialty pharmacy leaders from Canada, the UAE and the USA. Together, they will share global perspectives on specialty pharmacy practices, including clinical management, operational structures, quality standards, and patient care models unique to their regions.
Attendees will gain practical insights, real-world strategies, and cross-regional comparisons to support strengthening specialty pharmacy programmes and optimising patient outcomes. Panelists will respond to targeted questions in each category, offering actionable recommendations and lessons learned from their respective health systems.
Programme:
Learning objectives:
1. Explore the clinical, operational, and quality considerations for specialty pharmacy models across regions.
2. Learn actionable strategies for implementing or improving specialty pharmacy services within community or outpatient settings.
3. Gain insights into how global best practices can be adapted to improve patient care and streamline workflows.
Take home messages:
This session provides a unique opportunity to hear directly from international specialty pharmacy experts, offering practical tools, actionable recommendations, and cross-regional insights. By learning from global experiences, pharmacists can strengthen specialty pharmacy programmes and improve patient outcomes in their own settings.
FIP Development Goals:
To learn more about these FIP Development Goals, click on the links below.
FIP Development Goal 7: Advancing Integrated Services
FIP Development Goal 11: Impact and Outcomes
FIP Development Goal 15: People-Centred Care
| 14:15 – 14:25 | Introduction to specialty pharmacy |
| 14:25 – 14:55 | Panel discussion: Specialty pharmacy infrastructure across countries Moderated by Ms Zakieh Abuelkhair, Al Thiqa Pharmacy Group, UAE |
| 14:55 – 15:25 | Panel discussion: The specialty pharmacy patient journey Moderated by Ms Jill Paslier, Specia, USA |
| 15:25 – 15:40 | Panel discussion: Key challenges in specialty pharmacy Moderated by Dr Idan Reichhardt, Sanavie, Canada |
| 15:40 – 15:45 | Closing remarks by the chairs |
Chairs & speakers
Ms Rafa Al Khalifa
sec
UPF
Chairing of 113 - One Health in action: Global strategies for specialty pharmacy programmes
Ms Lynnae Mahaney
Swenson Pharmacy Advisors (SPA)
Chairing of 113 - One Health in action: Global strategies for specialty pharmacy programmes
Ms Zakieh Abuelkhair
Al Thiqa Pharmacy Group
Panel discussion
Ms Jill Paslier
Specia
Panel discussion
Dr Idan Reichhardt
Sanavie
Panel discussion